Payment overview · 2025
General Payments
$262.16
12 reported records · 8 companies
Healthcare provider profile · identity verified
Natalia Maximovsky, NP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health · STATEN ISLAND, NY · NPI 1265990097
Verified facts
What the public records show
CMS Open Payments records show Natalia Maximovsky, NP received $262.16 in general payments during 2025 across 12 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 31.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Eliquis, Linzess, Rexulti, Ztlido.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 222 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 657 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Lumigan by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 122 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported UBRELVY as an associated drug or biological on 299803 records involving 61203 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Ubrelvy by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 52 claims for Rexulti by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 916 claims for Eliquis by this doctor in 2024.
SCILEX PHARMACEUTICALS INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ZTLido as an associated drug or biological on 6923 records involving 3060 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Ztlido by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $82.68 | 31.5% | 4 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $40.04 | 15.3% | 2 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $29.65 | 11.3% | 1 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $27.79 | 10.6% | 1 | 2025 |
| SHIELD THERAPEUTICS INC | Unresolved — no canonical attribution shown | $23.95 | 9.1% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $23.61 | 9.0% | 1 | 2025 |
| SCILEX PHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $23.23 | 8.9% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $11.21 | 4.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $262.16 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $82.68 | 4 | 2025 |
Source payment records
|
|||||
| CREON Normalized: creon |
Drug | ABBVIE INC. | $40.04 | 2 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $40.04 | 2 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $29.65 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $29.65 | 1 | 2025 |
Source payment records
|
|||||
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $27.79 | 1 | 2025 |
Source payment records
|
|||||
| ACCRUFER Normalized: accrufer |
Drug | SHIELD THERAPEUTICS INC | $23.95 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $23.61 | 1 | 2025 |
Source payment records
|
|||||
| ZTLido Normalized: ztlido |
Drug | SCILEX PHARMACEUTICALS INC. | $23.23 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $11.21 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 222 | exact normalized | Medicare Part D |
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 916 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 657 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 52 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| ZTLido ztlido |
2025 | Ztlido | 2024 | 18 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
222 | 47 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
657 | 126 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
122 | 30 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | UBRELVY open payments reported associated product |
CMS Open Payments — General Payments 299803 supporting records · 61203 recipient NPIs · example record 1201352530 |
Ubrelvy · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
52 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
916 | 162 |
| SCILEX PHARMACEUTICALS INC. Exact reporting entity; no affiliate inference |
2025 | ZTLido open payments reported associated product |
CMS Open Payments — General Payments 6923 supporting records · 3060 recipient NPIs · example record 1242585247 |
Ztlido · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Diclofenac Sodium | Diclofenac Sodium | 1090 | 202 |
| Eliquis | Apixaban | 916 | 162 |
| Amlodipine Besylate | Amlodipine Besylate | 872 | 168 |
| Metoprolol Succinate | Metoprolol Succinate | 746 | 149 |
| Atorvastatin Calcium | Atorvastatin Calcium | 733 | 179 |
| Furosemide | Furosemide | 672 | 161 |
| Levothyroxine Sodium | Levothyroxine Sodium | 665 | 129 |
| Linzess | Linaclotide | 657 | 126 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 631 | 120 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 607 | 106 |
| Silver Sulfadiazine | Silver Sulfadiazine | 600 | 130 |
| Mupirocin | Mupirocin | 596 | 147 |
| Omeprazole | Omeprazole | 529 | 109 |
| Pantoprazole Sodium | Pantoprazole Sodium | 523 | 128 |
| Losartan Potassium | Losartan Potassium | 517 | 125 |
| Tamsulosin Hcl | Tamsulosin Hcl | 516 | 98 |
| Quetiapine Fumarate | Quetiapine Fumarate | 502 | 87 |
| Escitalopram Oxalate | Escitalopram Oxalate | 496 | 96 |
| Famotidine | Famotidine | 492 | 99 |
| Nystatin | Nystatin | 471 | 95 |
| Gabapentin | Gabapentin | 450 | 99 |
| Metoprolol Tartrate | Metoprolol Tartrate | 389 | 87 |
| Metformin Hcl | Metformin Hcl | 384 | 77 |
| Clopidogrel | Clopidogrel Bisulfate | 365 | 79 |
| Carvedilol | Carvedilol | 355 | 64 |
| Hydralazine Hcl | Hydralazine Hcl | 352 | 72 |
| Trazodone Hcl | Trazodone Hcl | 347 | 73 |
| Vascepa | Icosapent Ethyl | 343 | 55 |
| Mirtazapine | Mirtazapine | 313 | 58 |
| Ammonium Lactate | Ammonium Lactate | 311 | 66 |
| Memantine Hcl | Memantine Hcl | 307 | 45 |
| Lidocaine | Lidocaine | 304 | 67 |
| Donepezil Hcl | Donepezil Hcl | 299 | 56 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 291 | 47 |
| Ssd | Silver Sulfadiazine | 279 | 84 |
| Potassium Chloride | Potassium Chloride | 275 | 76 |
| Zenpep | Lipase/Protease/Amylase | 264 | 58 |
| Torsemide | Torsemide | 263 | 47 |
| Simvastatin | Simvastatin | 242 | 41 |
| Meclizine Hcl | Meclizine Hcl | 237 | 51 |
| Sertraline Hcl | Sertraline Hcl | 235 | 49 |
| Januvia | Sitagliptin Phosphate | 232 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 232 | 57 |
| Allopurinol | Allopurinol | 222 | 41 |
| Creon | Lipase/Protease/Amylase | 222 | 47 |
| Dexlansoprazole Dr | Dexlansoprazole | 217 | 39 |
| Memantine Hcl Er | Memantine Hcl | 216 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 207 | 52 |
| Icosapent Ethyl | Icosapent Ethyl | 186 | 38 |
| Clotrimazole | Clotrimazole | 185 | 51 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 183 | 42 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 182 | 72 |
| Fluticasone Propionate | Fluticasone Propionate | 167 | 63 |
| Levetiracetam | Levetiracetam | 164 | 28 |
| Lactulose | Lactulose | 156 | 50 |
| Azithromycin | Azithromycin | 151 | 135 |
| Clonazepam | Clonazepam | 150 | 34 |
| Ozempic | Semaglutide | 150 | 26 |
| Hydrochlorothiazide | Hydrochlorothiazide | 149 | 35 |
| Ranolazine Er | Ranolazine | 148 | 26 |
| Montelukast Sodium | Montelukast Sodium | 147 | 29 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 144 | 36 |
| Nifedipine Er | Nifedipine | 144 | 38 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 143 | 103 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 143 | 109 |
| Xarelto | Rivaroxaban | 142 | 27 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 140 | 24 |
| Tramadol Hcl | Tramadol Hcl | 136 | 56 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 135 | 88 |
| Clonidine Hcl | Clonidine Hcl | 132 | 45 |
| Tradjenta | Linagliptin | 132 | 24 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 128 | 19 |
| Synthroid | Levothyroxine Sodium | 122 | 30 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 120 | 55 |
| Ibuprofen | Ibuprofen | 118 | 45 |
| Proctozone-Hc | Hydrocortisone | 113 | 22 |
| Ketoconazole | Ketoconazole | 108 | 31 |
| Dicyclomine Hcl | Dicyclomine Hcl | 107 | 31 |
| Lorazepam | Lorazepam | 106 | 33 |
| Finasteride | Finasteride | 105 | 23 |
| Lisinopril | Lisinopril | 105 | 30 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 104 | 20 |
| Spironolactone | Spironolactone | 103 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 102 | 21 |
| Hydrocortisone | Hydrocortisone | 102 | 37 |
| Alprazolam | Alprazolam | 101 | 38 |
| Nyamyc | Nystatin | 101 | 26 |
| Entresto | Sacubitril/Valsartan | 98 | 20 |
| Procto-Med Hc | Hydrocortisone | 95 | 25 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 93 | 13 |
| Atenolol | Atenolol | 91 | 15 |
| Glipizide Er | Glipizide | 91 | 14 |
| Halobetasol Propionate | Halobetasol Propionate | 90 | 44 |
| Glimepiride | Glimepiride | 89 | 16 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 87 | 16 |
| Doxepin Hcl | Doxepin Hcl | 86 | 16 |
| Irbesartan | Irbesartan | 84 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 84 | 18 |
| Ventolin Hfa | Albuterol Sulfate | 84 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 81 | 19 |
| Telmisartan | Telmisartan | 79 | 11 |
| Latanoprost | Latanoprost | 78 | 14 |
| Loperamide | Loperamide Hcl | 76 | 38 |
| Alcohol Pads | Alcohol Antiseptic Pads | 74 | 20 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 74 | 14 |
| Ezetimibe | Ezetimibe | 73 | 15 |
| Ipratropium Bromide | Ipratropium Bromide | 73 | 44 |
| Labetalol Hcl | Labetalol Hcl | 73 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 73 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 73 | suppressed |
| Myrbetriq | Mirabegron | 72 | 14 |
| Prednisone | Prednisone | 72 | 36 |
| Valsartan | Valsartan | 72 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 70 | 11 |
| Dutasteride | Dutasteride | 69 | 14 |
| Nebivolol Hcl | Nebivolol Hcl | 69 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 67 | 12 |
| Megestrol Acetate | Megestrol Acetate | 67 | 13 |
| Meloxicam | Meloxicam | 67 | 24 |
| Metformin Hcl Er | Metformin Hcl | 67 | suppressed |
| Jardiance | Empagliflozin | 66 | 15 |
| Nitroglycerin Patch | Nitroglycerin | 66 | 14 |
| Cefuroxime | Cefuroxime Axetil | 63 | 50 |
| Trulicity | Dulaglutide | 62 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 61 | 29 |
| Nystop | Nystatin | 61 | 20 |
| Tresiba Flextouch U-100 | Insulin Degludec | 61 | 15 |
| Baclofen | Baclofen | 59 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 59 | 22 |
| Risperidone | Risperidone | 59 | 12 |
| Febuxostat | Febuxostat | 56 | 11 |
| Glipizide | Glipizide | 56 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 56 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 56 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 55 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 53 | 11 |
| Repatha Sureclick | Evolocumab | 52 | suppressed |
| Rexulti | Brexpiprazole | 52 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 51 | 15 |
| Pregabalin | Pregabalin | 51 | 11 |
| Digoxin | Digoxin | 50 | 16 |
| Methenamine Hippurate | Methenamine Hippurate | 48 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 47 | 14 |
| Celecoxib | Celecoxib | 46 | 19 |
| Enalapril Maleate | Enalapril Maleate | 46 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 46 | 17 |
| Ofloxacin | Ofloxacin | 46 | 28 |
| Mometasone Furoate | Mometasone Furoate | 44 | suppressed |
| Ramipril | Ramipril | 44 | 12 |
| Repaglinide | Repaglinide | 43 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 41 | suppressed |
| Bumetanide | Bumetanide | 41 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 41 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 41 | suppressed |
| Nitroglycerin | Nitroglycerin | 41 | 31 |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Amoxicillin | Amoxicillin | 40 | 33 |
| Ondansetron Odt | Ondansetron | 40 | 20 |
| Cephalexin | Cephalexin | 39 | 32 |
| Farxiga | Dapagliflozin Propanediol | 39 | suppressed |
| Mounjaro | Tirzepatide | 39 | 13 |
| Methimazole | Methimazole | 38 | suppressed |
| Rivastigmine | Rivastigmine | 38 | suppressed |
| Sucralfate | Sucralfate | 38 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 38 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 37 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 37 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 37 | suppressed |
| Belsomra | Suvorexant | 36 | suppressed |
| Colchicine | Colchicine | 36 | 11 |
| Cyclosporine | Cyclosporine | 36 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 36 | 22 |
| Fentanyl | Fentanyl | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 34 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Procrit | Epoetin Alfa | 34 | suppressed |
| Levofloxacin | Levofloxacin | 33 | 29 |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 33 | suppressed |
| Chlorthalidone | Chlorthalidone | 32 | suppressed |
| Methylprednisolone | Methylprednisolone | 32 | 29 |
| Rivastigmine | Rivastigmine Tartrate | 32 | suppressed |
| Fluconazole | Fluconazole | 31 | 20 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 31 | 13 |
| Cilostazol | Cilostazol | 30 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 30 | 18 |
| Diltiazem Hcl | Diltiazem Hcl | 29 | suppressed |
| Edarbi | Azilsartan Medoxomil | 28 | suppressed |
| Gemtesa | Vibegron | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 28 | 15 |
| Xiidra | Lifitegrast | 28 | suppressed |
| Ciprofloxacin-Dexamethasone | Ciprofloxacin Hcl/Dexameth | 27 | 17 |
| Clobetasol Propionate | Clobetasol Propionate | 27 | 12 |
| Jublia | Efinaconazole | 27 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 26 | suppressed |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 26 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 25 | suppressed |
| Clonidine | Clonidine | 25 | suppressed |
| Multaq | Dronedarone Hcl | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Diclofenac Epolamine | Diclofenac Epolamine | 24 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 24 | suppressed |
| Erythromycin | Erythromycin Base | 24 | 15 |
| Spiriva Handihaler | Tiotropium Bromide | 24 | suppressed |
| Ibu | Ibuprofen | 23 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 23 | suppressed |
| Olanzapine | Olanzapine | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 22 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 22 | suppressed |
| Terconazole | Terconazole | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Budesonide Er | Budesonide | 21 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 20 | suppressed |
| Metronidazole | Metronidazole | 20 | suppressed |
| Restasis | Cyclosporine | 20 | suppressed |
| Cefdinir | Cefdinir | 19 | 19 |
| Dexilant | Dexlansoprazole | 19 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 19 | suppressed |
| Lubiprostone | Lubiprostone | 19 | suppressed |
| Ubrelvy | Ubrogepant | 18 | suppressed |
| Ursodiol | Ursodiol | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Ztlido | Lidocaine | 18 | suppressed |
| Benicar Hct | Olmesartan/Hydrochlorothiazide | 17 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Enulose | Lactulose | 16 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Movantik | Naloxegol Oxalate | 15 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 15 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 14 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 14 | suppressed |
| Hydroxyurea | Hydroxyurea | 14 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Klayesta | Nystatin | 14 | suppressed |
| Mesalamine | Mesalamine | 14 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Nexium | Esomeprazole Magnesium | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Constulose | Lactulose | 12 | suppressed |
| Dexamethasone | Dexamethasone | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Rytary | Carbidopa/Levodopa | 12 | suppressed |
| Trulance | Plecanatide | 12 | suppressed |
| Zileuton Er | Zileuton | 12 | suppressed |
| Ambien Cr | Zolpidem Tartrate | 11 | suppressed |
| Apidra | Insulin Glulisine | 11 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Pimecrolimus | Pimecrolimus | 11 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 11 | suppressed |
| Propafenone Hcl Er | Propafenone Hcl | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $262.16 · 12 records | Otsuka America Pharmaceutical, Inc. | ACCRUFER, CREON, ELIQUIS, IBSRELA, LINZESS, NURTEC ODT, REXULTI, The Cologuard Plus Collection Kit, VOQUEZNA, ZTLido | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error